Israeli start-up uses ultrasound waves to treat Parkinson’s

News

Author: Simge Eva DoganPublished: 9 May 2019

Prep: Cook: Serves:

INSIGHTEC, a medical start-up based in Israel, is using ultrasound waves to treat Parkinson’s symptoms.

The treatment, called Exablate Neuro, uses non-invasive technology to alleviate tremors by directing high-intensity ultrasound beams to the VIM nucleus – the part of the brain where tremors are thought to originate.

Using specialist software, the ultrasound waves can also be used to provide surgeons with real-time feedback of any temperature changes in the areas being targeted.

Xen Mendelsohn Aderka, VP of marketing at INSIGHTEC, said: “The technology is being used in over 50 medical centres around the world, with over 2,000 neuro-patients treated.”

Aderka added that as the treatment is non-invasive, there is no risk of infection and patients can enjoy a rapid recovery.

INSIGHTEC obtained US Food and Drug Administration (FDA) approvals for its technology in 2016 and 2018.

To read more on this topic click here.

Could a transplant lower the risk of Parkinson’s?

Last Month

Next Month

Go Back

Share this story

Comments

Global update

Muhammad Ali’s daughter: “Dad, you are a pearl embedded in the oyster of life”

WPC highlights: May May Ali and Brian Grant at the opening ceremony

Picturing Parkinson’s: scientists capture brain cells in striking detail

Amazing images show Parkinson’s brain cells in microscopic detail

Advances

EU approval for Medtronic DBS systems improves access to full-body MRI scans

Patients receiving DBS therapy have the option of full-body MRI scans

A “revolutionary” step in stem cell therapy for Parkinson’s disease?

Scientists in China have developed a method to help improve stem cell research in mice models of Parkinson’s – which could potentially lead to promising new treatments. The researchers, based at the Chinese Academy of Sciences, identified two cell surface markers of dopamine neurons, which are reduced in Parkinson’s. They injected cells with these markers into the brains of the mice and found that this resulted in “higher therapeutic potency” for improving motor symptoms of the condition. As part of their research, the team also worked to control the variability of donor cells, to help improve therapeutic outcomes for Parkinson’s cell therapy. The researchers, whose study was published in ‘The Journal of Clinical Investigation’, described the findings as a “revolutionary step on the road towards more effective and safer stem cell therapies”.

Could frequent nightmares be an early sign of Parkinson’s disease?

A new study has suggested that experiencing recurrent nightmares and bad dreams could be an early symptom of Parkinson’s disease. Researchers from the University of Birmingham, UK, used data from an existing US study that followed 3818 men, aged 67 or older, over a period of 12 years. Participants who reported experiencing bad dreams at least once a week were followed up. During the follow up, 91 people were diagnosed with Parkinson’s. The results suggested that participants who had frequent bad dreams were twice as likely to develop the condition as those who did not. Commenting on the study, lead author Dr Abidemi Otaiku said: “While we need to carry out further research, identifying the significance of bad dreams and nightmares could indicate that individuals who experience changes to their dreams in older age – without any obvious trigger – should seek medical advice.”

More than £2m awarded to research on mitochondria and Parkinson’s disease

Researchers at UK biotech startup NRG Therapeutics are developing potential treatments that may help slow the progression of Parkinson’s by protecting the mitochondria – a part of every human cell that works to power chemical reactions. The company has now received a £2.68m award from government-backed agency Innovate UK to continue its research. Their research built upon previous findings that damage to mitochondria in the substantia nigra – an area of the brain associated with dopamine – may be linked to Parkinson’s. The scientists developed molecules that keep a ‘pore’ in the mitochondria closed, which stops calcium flowing into it, preventing a process that eventually ruptures the powerhouse of the cell and leads to its death. The new funding award follows previous investment from Parkinson’s UK and the Michael J Fox Foundation.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Israeli start-up uses ultrasound waves to treat Parkinson’s

News

Author: Simge Eva DoganPublished: 9 May 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

Muhammad Ali’s daughter: “Dad, you are a pearl embedded in the oyster of life”

Europe

Picturing Parkinson’s: scientists capture brain cells in striking detail

sponsored article

Advances

EU approval for Medtronic DBS systems improves access to full-body MRI scans

A “revolutionary” step in stem cell therapy for Parkinson’s disease?

Could frequent nightmares be an early sign of Parkinson’s disease?

More than £2m awarded to research on mitochondria and Parkinson’s disease

{title}

Subscribe

Israeli start-up uses ultrasound waves to treat Parkinson’s

News

Author: Simge Eva DoganPublished: 9 May 2019

Last Month

Next Month

Share this story

Comments

Related articles

Global update

Muhammad Ali’s daughter: “Dad, you are a pearl embedded in the oyster of life”

Europe

Picturing Parkinson’s: scientists capture brain cells in striking detail

sponsored article

Advances

EU approval for Medtronic DBS systems improves access to full-body MRI scans

A “revolutionary” step in stem cell therapy for Parkinson’s disease?

Could frequent nightmares be an early sign of Parkinson’s disease?

More than £2m awarded to research on mitochondria and Parkinson’s disease

{title}

Subscribe

Sign in